Ebastine improves nasal symptoms and airflow and affects response to decongestion test in patients with persistent allergic rhinitis: A pilot study

Allergy and Asthma Proceedings

Volumn 28, Issue 5, 2007, Pages 578-581

  Ciprandi, Giorgio ^a   Cirillo, Ignazio ^b   Mora, Francesco ^a   La Rosa, Mario ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b Servizio Sanitario   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Decongestion test; Ebastine; Nasal airflow; Nasal obstruction; Persistent allergic rhinitis

Indexed keywords

EID: 36648998509     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.3029     Document Type: Article

References (15)

1. Horak F. Impact and modulation of nasal obstruction. Allergy 57:25-28, 2002.
2. Ciprandi G, Cirillo I, Klersy C, et al. The response to decongestion test is associated with sensitizations and allergic inflammation. Anns Allergy Asthma Immunol 96:431-436, 2006.
3. Bousquet J. Requirements for medication commonly used in the treatment of allergic rhinitis. Allergy 58:192-197, 2003.
4. Gentile DA, Friday GA, and Skoner DP. Management of allergic rhinitis: antihistamines and decongestants. Immunol Clin North Am 20:355-368, 2000.
5. Bachert C, Brostoff J, Scadding GK, et al. Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhino-conjunctivitis. Allergy 53:969-975, 1998.
6. Horak F, Stubner UP, Ziegelmayer R, and Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 109:956-961, 2002.
7. Ciprandi G, Cosentino C, Milanese M, et al. Fexofenadine treatment reduces nasal congestion in allergic rhinitis. Allergy 56: 1068-1070, 2001.
8. Roberts DJ. A preclinical overview of ebastine. Studies on the pharmacological properties of a novel histamine H1 receptor antagonist. Drugs 52:8-14, 1996.
9. Campbell A, Michel FB, Bremard-Oury C, et al. Overview of allergic mechanisms: Ebastine has more than an Antihistamine effect. Drugs 52(suppl 1):15-19, 1996.
10. Horiguchi T, Tachikawa S, Kasahara J, et al. Effect of ebastine on serum eosinphil cationic protein levels in patients with bronchial asthma. Clin Drug Invest 17:435-440, 1999.
11. Roumenstan C, Henriquet C, Mathieu M, et al. Effect of ebastine and carebastine on pro-inflammatory chemokines and transcription factors. J World Allergy Organ Suppl 1:738, 2005.
12. Ratner D, Hampel DF, and Gispert J. Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis. Method Find Exp Clin Pharmacol 25:111-115, 2003.
13. Bousquet J, Van Cauwenberge P, and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108(suppl 5):S147-S334, 2001.
14. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Nasal obstruction in patients with seasonal allergic rhinitis: Relationships between allergic inflammation and nasal airflow. Int Arch Allergy Immunol 134:34-40, 2004.
15. Tsicopoulos M, and de Nadai P. Antihistamines as anti-inflammatory agents. Clin Exp Allergy 33:1476-1478, 2003.